Revista nº 809

Carrillo-Avila J.A. Virus emergentes y nuevas zoonosis · 9 · Actualidad Médica · Número 809 · Enero/Abril 2020 Páginas 7 a 10 REFERENCIAS BIBLIOGRÁFICAS 1. Taylor LH, Latham SM, Woolhouse ME. 2001. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 356:983-9. 2. Parvez MK, Parveen S. 2017. Evolution and Emergence of Pathogenic Viruses: Past, Present, and Future. Intervirology 60:1-7. 3. WHO. Spanish flu 1918 https://www.cdc.gov/flu/ pandemic-resources/reconstruction-1918-virus.html. 4. CDC. Pandemic N1N1 flu 2009 https://www.cdc.gov/flu/ spotlights/pandemic-global-estimates.htm. 5. WHO. H5N1 (Avian flu) https://www.who.int/influenza/ human_animal_interface/H5N1_cumulative_table_ archives/en/. 6. Loeffelholz MJ, Tang YW. 2020. Laboratory Diagnosis of Emerging Human Coronavirus Infections - The State of the Art. Emerg Microbes Infect doi:10.1080/22221751.2020.1745095:1-26. 7. Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF. 2016. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol 24:490-502. 8. Makela MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimaki M, Blomqvist S, Hyypia T, Arstila P. 1998. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 36:539-42. 9. Sipulwa LA, Ongus JR, Coldren RL, Bulimo WD. 2016. Molecular characterization of human coronaviruses and their circulation dynamics in Kenya, 2009-2012. Virol J 13:18. 10. Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE. 2010. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol 48:2940-7. 11. Dominguez SR, Robinson CC, Holmes KV. 2009. Detection of four human coronaviruses in respiratory infections in children: a one-year study in Colorado. J Med Virol 81:1597-604. 12. Killerby ME, Biggs HM, Haynes A, Dahl RM, Mustaquim D, Gerber SI, Watson JT. 2018. Human coronavirus circulation in the United States 2014-2017. J Clin Virol 101:52-56. 13. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348:1953-66. 14. WHO. SARS (severe acute respiratory syndrome). https:// www.who.int/ith/diseases/sars/en/ (accessed April 20, 2020). 15. Hijawi B, Abdallat M, Sayaydeh A, Alqasrawi S, Haddadin A, Jaarour N, Alsheikh S, Alsanouri T. 2013. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J 19 Suppl 1:S12-8. 16. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814-20. 17. WHO. MERS (Middle East respiratory syndrome coronavirus). https://www.who.int/emergencies/mers- cov/en/ (accessed April 20, 2020). 18. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270-273. 19. Zhang T, Wu Q, Zhang Z. 2020. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak. Curr Biol doi:10.1016/j.cub.2020.03.022. 20. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W. 2020. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 382:727-733. 21. WHO. Coronavirus disease (COVID-19) Pandemic. https:// www.who.int/emergencies/diseases/novel-coronavirus-2019. Situation Report 97. (accessed April 27, 2020). 22. Li X, Wang W, Zhao X, Zai J, Zhao Q, Li Y, Chaillon A. 2020. Transmission dynamics and evolutionary history of 2019- nCoV. J Med Virol 92:501-511. 23. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497-506. 24. Wang Z, Yang B, Li Q, Wen L, Zhang R. 2020. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis doi:10.1093/cid/ciaa272. 25. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, Yuan Q, Xiao X. 2020. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis doi:10.1007/ s10096-020-03874-z. 26. Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. 2020. Urticarial eruption in COVID-19 infection. J Eur Acad Dermatol Venereol doi:10.1111/jdv.16472. 27. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. 2020. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis doi:10.1016/S1473- 3099(20)30195-X. 28. Padoan A, Cosma C, Sciacovelli L, Faggian D, Plebani M. 2020. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics. Clin Chem Lab Med doi:10.1515/cclm-2020-0443. 29. Bedir Demirdag T, Tezer H. 2020. Novel Coronavirus disease (COVID-19) in children. Turk J Med Sci doi:10.3906/sag- 2004-174. 30. Saif L. 2020. Vaccines for COVID-19: perspectives, prospects, and challenges based on candidate SARS, MERS, and animal coronavirus vaccines. . European Medical Journal Doi: 1033590/emj/200324. 31. CDC. Research Use Only 2019-Novel Coronavirus (2019- nCoV) Real-time RT-PCR Primer and Probe Information. https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr- panel-primer-probes.html. 32. Tahamtan A, Ardebili A. 2020. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev Mol Diagn doi:10.1080/14737159.2020.1757437.